Search research articles
Contact Us
Filters
Showing results (11-20 of 104) with videos related to
Page
of 11
Sort By:
Minerva Urology and Nephrology
|
January 20, 2025
YAU renal cancer spotlight: how should cost-effectiveness affect decision-making regarding adjuvant pembrolizumab for clear cell renal cell carcinoma?
Selcuk Erdem, Laura Marandino, Eduard Roussel, et al.
Minerva Urology and Nephrology
|
December 21, 2023
"Sutureless success:" can new devices make renorrhaphy after partial nephrectomy obsolete?
Eduard Roussel, Daniele Amparore, Riccardo Bertolo, et al.
Minerva Urology and Nephrology
|
September 8, 2021
Renal tumors ablation
Michele Marchioni, Daniele Amparore, Alexandre Ingels, et al.
European Urology Oncology
|
November 19, 2023
Re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274
Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al.
Minerva Urology and Nephrology
|
August 2, 2023
Renal cell carcinoma with non-clear cell histologies: all the same peas in one pod?
Eduard Roussel, Daniele Amparore, Riccardo Bertolo, et al.
Minerva Urology and Nephrology
|
December 21, 2023
The World Health Organization 2022 Classification of renal tumors: key updates for urologists
Anna Caliò, Daniele Amparore, Eduard Roussel, et al.
European Urology
|
February 26, 2022
Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review
Eduard Roussel, Umberto Capitanio, Alexander Kutikov, et al.
Urologic Oncology
|
January 24, 2021
C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab
Eduard Roussel, Lisa Kinget, Annelies Verbiest, et al.
Scandinavian Journal of Urology
|
September 14, 2020
Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinoma
Eduard Roussel, Annelies Verbiest, Uros Milenkovic, et al.
Urologic Oncology
|
September 9, 2020
Pushing the limits of metastasis-directed treatment in metastatic renal cell carcinoma in the era of targeted therapy
Serge Holz, Lorenzo Tosco, Murat Akand, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 104) with videos related to
Sort By:
Page
of 11
Minerva Urology and Nephrology
|
January 20, 2025
YAU renal cancer spotlight: how should cost-effectiveness affect decision-making regarding adjuvant pembrolizumab for clear cell renal cell carcinoma?
Selcuk Erdem, Laura Marandino, Eduard Roussel, et al.
Minerva Urology and Nephrology
|
December 21, 2023
"Sutureless success:" can new devices make renorrhaphy after partial nephrectomy obsolete?
Eduard Roussel, Daniele Amparore, Riccardo Bertolo, et al.
Minerva Urology and Nephrology
|
September 8, 2021
Renal tumors ablation
Michele Marchioni, Daniele Amparore, Alexandre Ingels, et al.
European Urology Oncology
|
November 19, 2023
Re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274
Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al.
Minerva Urology and Nephrology
|
August 2, 2023
Renal cell carcinoma with non-clear cell histologies: all the same peas in one pod?
Eduard Roussel, Daniele Amparore, Riccardo Bertolo, et al.
Minerva Urology and Nephrology
|
December 21, 2023
The World Health Organization 2022 Classification of renal tumors: key updates for urologists
Anna Caliò, Daniele Amparore, Eduard Roussel, et al.
European Urology
|
February 26, 2022
Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review
Eduard Roussel, Umberto Capitanio, Alexander Kutikov, et al.
Urologic Oncology
|
January 24, 2021
C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab
Eduard Roussel, Lisa Kinget, Annelies Verbiest, et al.
Scandinavian Journal of Urology
|
September 14, 2020
Too good for CARMENA: criteria associated with long systemic therapy free intervals post cytoreductive nephrectomy for metastatic clear cell renal cell carcinoma
Eduard Roussel, Annelies Verbiest, Uros Milenkovic, et al.
Urologic Oncology
|
September 9, 2020
Pushing the limits of metastasis-directed treatment in metastatic renal cell carcinoma in the era of targeted therapy
Serge Holz, Lorenzo Tosco, Murat Akand, et al.
Page
of 11